Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiomyopathy VI: Nursing Management

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Very low calorie diet versus conventional energy-restricted diet for weight loss before bariatric surgery. A randomized controlled trial.

Obesity research & clinical practice·2026

Same author

[Leptin treatment of multiple symmetric lipomatosis due to a mitochondrial defect].

Ugeskrift for laeger·2026

Same author

Editorial: Components Separation Techniques in Abdominal Wall Surgery.

Journal of abdominal wall surgery : JAWS·2026

Same author

Emergency parastomal hernia repair - a systematic review.

Hernia : the journal of hernias and abdominal wall surgery·2025

Same author

Short- and long-term complications after slowly resorbable biosynthetic P4HB mesh (Phasix) implantation in European centres: a protocol paper for a multiregistry study.

BMJ open·2025

Same author

Body mass index and mental disorders: A Danish cohort study.

Diabetes, obesity & metabolism·2025

Search research articles

Related Experiment Video

Updated: Jul 18, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

[The obese patient].

Lars Nannestad Jørgensen¹, Odd Ravlo, Bjørn Richelsen

¹H:S Bispebjerg Hospital, Kirurgisk Afdeling K, Aalborg Sygehus, København NV. larsnjorgensen@hotmail.com

Ugeskrift for Laeger

|December 14, 2006

Summary

Managing anesthesia in obese patients presents challenges due to altered physiological functions and increased infection risk. Surgical risk is linked more to comorbidity than BMI, advocating against discrimination in surgical consideration.

Area of Science:

Anesthesiology
Bariatric Surgery
Critical Care Medicine

Context:

Obesity presents unique physiological challenges for anesthesia, including respiratory and circulatory alterations.
Obese patients face an elevated risk of nosocomial infections, such as wound sepsis.
The optimal role of minimally invasive surgery in mitigating complications for this population remains under investigation.

Purpose:

To review the anesthetic and surgical considerations for obese patients.
To highlight the need for weight-adjusted prophylactic antibiotics and antithrombotics.
To emphasize that surgical risk is primarily associated with comorbidity, not body mass index (BMI).

Summary:

Anesthesia for obese patients is complex due to physiological changes and increased infection risks.

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Related Experiment Videos

Last Updated: Jul 18, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Prophylactic, weight-adjusted antithrombotics and antibiotics are necessary.

Surgical risk correlates with comorbidity, irrespective of BMI.

Impact:

This review supports informed decision-making regarding surgical options for obese patients.
It advocates for equitable access to surgery, preventing discrimination based on BMI.
Highlights the importance of personalized risk assessment considering comorbidities over BMI.